Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 40 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
11 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
NUTRIPHYT from Gent, company number BE0478698859, closed financial year 2025 with a result of € -1.1 million after tax. For that financial year NUTRIPHYT recorded a gross margin of € 2.4 million and equity of € 453,740. Compared with financial year 2024, the result moved from € -286,399 to € -1.1 million. The company made a loss. The buffer shrank hard: equity is 70 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 453,740
▼ 70% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1.1 million
▼ 275 % more loss than in 2024
Profit after tax over the fiscal year.
€ 153,015
▲ 24% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 257,240.
People and assets in 2025
22.3
▲ 5.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 2 million
▲ 67% vs 2024
€ 91,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 122,774
▼ 48% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 2.9 million
▼ 17% vs 2024
€ 531,549 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 398,087
▲ 34% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 326,755
▲ 128% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,290,663 | € 1,616,312 | € 1,448,143 | € 2,391,739 | ▲ 65% |
| Profit after taxes | € 151,623 | € 226,189 | € -286,399 | € -1,073,110 | ▼ € 786,711 |
| Equity | € 1,587,061 | € 1,813,249 | € 1,526,850 | € 453,740 | ▼ 70% |
| Total debts | € 1,775,044 | € 4,767,076 | € 4,565,281 | € 4,676,928 | ▲ 2% |
| Cash | € 386,483 | € 350,374 | € 123,795 | € 153,015 | ▲ 24% |
| Land & buildings | € 896,424 | € 860,976 | € 836,927 | € 796,997 | ▼ 5% |
| Retained profit | € 1,390,561 | € 1,616,749 | € 1,330,350 | € 257,240 | ▼ 81% |
| Bank debt | € 946,314 | € 3,822,041 | € 3,496,289 | € 2,915,023 | ▼ 17% |
| Balance sheet total | € 3,362,105 | € 6,580,325 | € 6,092,131 | € 5,130,668 | ▼ 16% |
| Employees (FTE) | 13.3 | 12.3 | 16.8 | 22.3 | ▲ 5.5 |
Key figures of NUTRIPHYT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to NUTRIPHYT?
What happened at NUTRIPHYT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Smard BV stepped down as director. NBB
- Erudite BV stepped down as director. NBB
- Erudite.health BV stepped down as director. NBB
- Lucalot BV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 1.1 million. Source: NBB ↗
- Hadewijch Devriendt stepped down as director. NBB
- Pure Lynn BV stepped down as director. NBB
- Lucalot BV became a director. NBB
In short
From € 151,623 profit in 2022 to € 1.1 million loss in 2025.
Paid € 242,999 in corporate taxes since 2022.
Best year ever: 2023, with € 226,189 profit.
On average € 107,300 of value added per employee in 2025.
A new publication or filing at NUTRIPHYT? We notify you, reason included.
Follow NUTRIPHYTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Erudite.Health, Pure Lynn comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
NUTRIPHYTThe shares are held by Erudite.Health (100%) and Pure Lynn (11.7%). It owns 100% of Nutriphyt Nederland BV itself.
Directors
According to the 2025 annual accounts
since 2024 · until 2029
Hadewijch Devriendt
Director
since 2023 · until 2025
Managing director · represented by Louis Declerck
Also active at: T.DIFFUSION, S.A. Laboratoires Pharmaceutiques Trenker, ROBINWOOD, TRENKER NUTRITION, Erudite.Health, Trenker HoldCo, Erudite Corporate
since 2023 · until 2029
Managing director · represented by Herlinde Devriendt
since 2023 · until 2025
Director · represented by Charles Declerck
since 2024 · until 2029
Director · represented by Filip Meire
Also active at: Ace Law, Erudite.Health, Complissimo
since 2025 · until 2029
Shareholders
100%
11.7%
Participations
Nutriphyt Nederland BV
100%
Establishments
Establishment units
Physical locations of this company
Kortrijksesteenweg 1084 box .0204
9051 Gent
Kortrijksesteenweg 1084/0204
9051 Gent
Active since 18 November 2002
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 11 companies are registered at this address.
All companies at this address →CANTILLANA
€ 33.8 million revenue · 2025
Cantillana Group
XEOS MEDICAL
€ -1.5 million gross margin · 2025
Erudite.Health same network
€ -485,799 gross margin · 2025
Fire Engineered Solutions
€ 2.7 million gross margin · 2025
+6 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0478.698.859
- VAT number
- BE 0478.698.859
- Registered office
- Kortrijksesteenweg 1084 bus .0204, 9051 Gent
- Names & denominations
- NUTRIPHYT
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 30 October 2002
- Peppol
- Active · Active since 26 Sept 2025
- Activities · NACE
Overige gespecialiseerde groothandel in voedingswaren
Groothandel in andere voedingsmiddelen, neg